Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing company, according to people familiar with the matter.

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in Finance & Markets

More from Wednesday 21 October →